Tranexamic acid for the treatment of post-partum haemorrhage: An International randomized, double blind placebo controlled trial. - Woman Trial

Indian Council of Medical Research ICMR0 个研究点目标入组 15,000 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•All legally adult women with clinically diagnosed postpartum haemorrhage following vaginal delivery of a baby or caesarean section; women may have delivered their babies at a participating hospital of outside a participating hospital, with hospital admission following delivery:
•Where the responsible clinician is substantially uncertain as to whether or not to use TXA
•When consent has been given according to approved procedures.
•The clinical diagnosis of PPH may be based on any of the following:
•Estimated blood loss after vaginal delivery of a baby >500 mL OR
•>1000 mL from caesarean section OR
•Estimated blood loss enough to compromise the haemodynamic status of the woman.

•Women for whom the responsible clinician considers there is a clear indication for TXA should not be randomized.
•Women for whom the responsible clinician considers there is a clear contraindication for TXA should not be randomized (e.g. a known thrombembolic even during pregnancy)

发起方

Indian Council of Medical Research ICMR